CLINICAL_TRIALS
trial_result
· 2023-10-31
Clinical Trial Update: Panobinostat and Ruxolitinib In MyElofibrosis (PRIME Trial) [Phase 1, Phase 2]
Summary
Phase 1/2 trial evaluating panobinostat and ruxolitinib in myelofibrosis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: John Mascarenhas | Conditions: Myelofibrosis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-10-31